A Multicenter Evaluation of the US Prevalence and Regional Variation in Macrolide-Resistant

Streptococcus pneumoniae antibiotic resistance community-acquired pneumonia epidemiology macrolides

Journal

Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045

Informations de publication

Date de publication:
Jul 2021
Historique:
received: 10 11 2020
accepted: 29 01 2021
entrez: 12 7 2021
pubmed: 13 7 2021
medline: 13 7 2021
Statut: epublish

Résumé

Macrolide resistance was found in 39.5% of 3626 nonduplicate

Identifiants

pubmed: 34250183
doi: 10.1093/ofid/ofab063
pii: ofab063
pmc: PMC8266646
doi:

Types de publication

Journal Article

Langues

eng

Pagination

ofab063

Commentaires et corrections

Type : CommentIn

Informations de copyright

Published by Oxford University Press on behalf of Infectious Diseases Society of America 2021.

Références

Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):12896-12901
pubmed: 30559195
Clin Infect Dis. 2017 Nov 13;65(11):1806-1812
pubmed: 29020164
Curr Opin Infect Dis. 2019 Apr;32(2):169-175
pubmed: 30640820
N Engl J Med. 2013 Jul 11;369(2):155-63
pubmed: 23841730
N Engl J Med. 2014 Oct 23;371(17):1619-28
pubmed: 25337751
Front Immunol. 2018 Jun 22;9:1366
pubmed: 29988379
Lancet Infect Dis. 2018 Nov;18(11):1191-1210
pubmed: 30243584
PLoS Med. 2014 Feb 04;11(2):e1001598
pubmed: 24503544
Emerg Infect Dis. 2009 Aug;15(8):1260-4
pubmed: 19751588
Clin Microbiol Infect. 2020 Jun;26(6):753-759
pubmed: 31756452
Open Forum Infect Dis. 2018 Sep 21;5(10):ofy241
pubmed: 30364442
J Antimicrob Chemother. 2019 Aug 1;74(Suppl 4):iv39-iv47
pubmed: 31505644
Clin Infect Dis. 2021 Mar 1;72(5):797-805
pubmed: 32067037
Infect Control Hosp Epidemiol. 2013 Jun;34(6):588-96
pubmed: 23651889
JAMA. 2020 Jun 23;323(24):2524-2526
pubmed: 32463459
Eur J Clin Microbiol Infect Dis. 2020 Aug;39(8):1513-1525
pubmed: 32242314
JAMA. 2019 Nov 5;322(17):1661-1671
pubmed: 31560372
J Infect Dis. 2004 Jun 1;189(11):1996-2000
pubmed: 15143465
MMWR Morb Mortal Wkly Rep. 2013 Feb 15;62(6):103-6
pubmed: 23407126
Open Forum Infect Dis. 2020 Feb 26;7(3):ofaa065
pubmed: 32195289
Am J Respir Crit Care Med. 2019 Oct 1;200(7):e45-e67
pubmed: 31573350
JAMA. 2016 May 3;315(17):1864-73
pubmed: 27139059
J Clin Microbiol. 2019 Oct 23;57(11):
pubmed: 31484702
Pediatr Infect Dis J. 2020 Apr;39(4):339-344
pubmed: 31815827
Clin Infect Dis. 2020 Oct 23;71(7):1604-1612
pubmed: 31665249
Travel Med Infect Dis. 2018 Jul - Aug;24:89-100
pubmed: 29860151
Antimicrob Agents Chemother. 2018 Jan 25;62(2):
pubmed: 29158271
Open Forum Infect Dis. 2019 Mar 15;6(Suppl 1):S14-S23
pubmed: 30895211
Infect Control Hosp Epidemiol. 2019 Nov;40(11):1229-1235
pubmed: 31522695

Auteurs

Vikas Gupta (V)

Becton, Dickinson and Company, Franklin Lakes, New Jersey, USA.

Kalvin C Yu (KC)

Becton, Dickinson and Company, Franklin Lakes, New Jersey, USA.

Jennifer Schranz (J)

Nabriva Therapeutics US, Inc., King of Prussia, Pennsylvania, USA.

Steven P Gelone (SP)

Nabriva Therapeutics US, Inc., King of Prussia, Pennsylvania, USA.

Classifications MeSH